Journal of Research in Pharmacy Practice

BRIEF COMMUNICATION
Year
: 2012  |  Volume : 1  |  Issue : 2  |  Page : 77--80

The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study


Farahnaz Fatemi Naini1, Alireza Vaez Shooshtari3, Bahareh Ebrahimi2, Razieh Molaei3 
1 Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran; Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan; Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
2 Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
3 Cell and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

Correspondence Address:
Bahareh Ebrahimi
Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan
Iran

Objective : Pseudocatalase/superoxide dismutase (PSD) is a topical gel considered having therapeutic effects in vitiligo. This study was designed to evaluate the efficacy of this combination in vitiligo. Methods : This was a pilot randomized, double-blind, placebo-controlled trial on 46 symmetrical vitiligo lesions of limbs in 23 patients referring to dermatology clinics, Isfahan, Iran in 2010. Patients were received this formula or placebo gels for the right and left lesions. Lesion area and degree of pigmentation were assessed at baseline, 2, 4, and 6 months. Findings : There were no significant changes in lesion area and perifollicular pigmentation in each group (P > 0.05). Conclusion : The results indicated no significant therapeutic effect for PSD in vitiligo.


How to cite this article:
Naini FF, Shooshtari AV, Ebrahimi B, Molaei R. The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study.J Res Pharm Pract 2012;1:77-80


How to cite this URL:
Naini FF, Shooshtari AV, Ebrahimi B, Molaei R. The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study. J Res Pharm Pract [serial online] 2012 [cited 2022 Jul 2 ];1:77-80
Available from: https://www.jrpp.net/article.asp?issn=2319-9644;year=2012;volume=1;issue=2;spage=77;epage=80;aulast=Naini;type=0